Search Results - "Pruente, C"

Refine Results
  1. 1

    Treat & extend versus PRN in AMD by Pruente, C.

    Published in Acta ophthalmologica (Oxford, England) (01-10-2016)
    “…Summary Basically 3 different approaches to anti‐VEGF treatment in AMD are in clinical use, a fixed regimen using monthly or bi‐monthly injections (IVI), a PRN…”
    Get full text
    Journal Article
  2. 2

    Effect of intravitreal ranibizumab in avascular pigment epithelial detachment by Ritter, M, Bolz, M, Sacu, S, Deák, G G, Kiss, C, Pruente, C, Schmidt-Erfurth, U M

    Published in Eye (London) (01-06-2010)
    “…Purpose To evaluate long-term morphologic and functional changes after intravitreal ranibizumab in avascular pigment epithelial detachment (PED) secondary to…”
    Get full text
    Journal Article
  3. 3

    Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results by Sacu, S, Michels, S, Prager, F, Weigert, G, Dunavoelgyi, R, Geitzenauer, W, Pruente, C, Schmidt-Erfurth, U

    Published in Eye (London) (01-12-2009)
    “…Purpose To compare 1-year functional and anatomic outcomes of intravitreal bevacizumab (IVB) and photodynamic therapy plus intravitreal triamcinolone…”
    Get full text
    Journal Article
  4. 4

    Comparison of retinal thickness values and segmentation performance of different OCT devices in acute branch retinal vein occlusion by Matt, G, Sacu, S, Buehl, W, Ahlers, C, Dunavoelgyi, R, Pruente, C, Schmidt-Erfurth, U

    Published in Eye (London) (01-04-2011)
    “…Purpose To compare retinal thickness (RT) measurement and segmentation performance of time domain (TD, Stratus) and spectral domain (SD) optical coherence…”
    Get full text
    Journal Article
  5. 5

    Thirty-month follow-up after intravitreal bevacizumab in progressive idiopathic macular telangiectasia type 2 by Matt, G, Sacu, S, Ahlers, C, Schütze, C, Dunavoelgyi, R, Prager, F, Pruente, C, Schmidt-Erfurth, U

    Published in Eye (London) (01-10-2010)
    “…Aim The aim of this study is to evaluate the long-term efficacy of intravitreal bevacizumab (IVB) for eyes with non-proliferative idiopathic macular…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Topographic angiography and optical coherence tomography: a correlation of imaging characteristics by Ahlers, C, Michels, S, Elsner, H, Birngruber, R, Pruente, C, Schmidt-Erfurth, U

    Published in European journal of ophthalmology (01-11-2005)
    “…Topographic angiography (TAG) using confocal scanning laser angiography and optical coherence tomography (OCT) are new imaging modalities that have been…”
    Get full text
    Journal Article
  8. 8

    Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials by Mitchell, P, Korobelnik, J-F, Lanzetta, P, Holz, F G, Prünte, C, Schmidt-Erfurth, U, Tano, Y, Wolf, S

    Published in British journal of ophthalmology (01-01-2010)
    “…Neovascular age-related macular degeneration (AMD) has a poor prognosis if left untreated, frequently resulting in legal blindness. Ranibizumab is approved for…”
    Get more information
    Journal Article
  9. 9

    Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin) by Georgopoulos, M, Polak, K, Prager, F, Prünte, C, Schmidt-Erfurth, U

    Published in British journal of ophthalmology (01-04-2009)
    “…To report a series of severe intraocular inflammatory events following intravitreal injections of bevacizumab (Avastin). This procedure is performed on a…”
    Get more information
    Journal Article
  10. 10

    New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel by Bandello, F, Cunha-Vaz, J, Chong, N V, Lang, G E, Massin, P, Mitchell, P, Porta, M, Prünte, C, Schlingemann, R, Schmidt-Erfurth, U

    Published in Eye (London) (01-04-2012)
    “…The current standard therapy for patients with diabetic macular oedema (DME)—focal/grid laser photocoagulation—usually does not improve impaired vision, and…”
    Get full text
    Journal Article
  11. 11

    Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration by Bolz, M, Simader, C, Ritter, M, Ahlers, C, Benesch, T, Prünte, C, Schmidt-Erfurth, U

    Published in British journal of ophthalmology (01-02-2010)
    “…To quantify and correlate the morphological and functional effects of the recommended loading regimen with intravitreal ranibizumab in neovascular age-related…”
    Get more information
    Journal Article
  12. 12

    Early foveal recovery after macular hole surgery by Hasler, P W, Prünte, C

    Published in British journal of ophthalmology (01-05-2008)
    “…To evaluate morphological and functional recovery after macular hole surgery using pars plana vitrectomy (PPV), inner limiting membrane (ILM) peeling,…”
    Get more information
    Journal Article
  13. 13

    Analysis of Peripapillary Atrophy in Relation to Macular Geographic Atrophy in Age-Related Macular Degeneration by Chang, Petrus, Tan, Anna, Jaffe, Glenn J, Fleckenstein, Monika, Holz, Frank G, Schmitz-Valckenberg, Steffen

    “…The purpose of this study was to investigate the presence, configuration, and progression of peripapillary atrophy (PPA) relative to macular geographic atrophy…”
    Get full text
    Journal Article
  14. 14

    Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration by Sacu, S, Stifter, E, Vécsei-Marlovits, P V, Michels, S, Schütze, C, Prünte, C, Schmidt-Erfurth, U

    Published in Eye (London) (01-06-2009)
    “…Background To evaluate the clinical outcomes of subfoveal haemorrhages secondary to neovascular age-related macular degeneration (AMD), which were treated with…”
    Get full text
    Journal Article
  15. 15

    Combination of Intravitreal rTPA, gas and ranibizumab for extensive subfoveal haemorrhages secondary to neovascular age-related macular degeneration by Matt, G, Sacu, S, Stifter, E, Prünte, C, Schmidt-Erfurth, U

    Published in Klinische Monatsblatter fur Augenheilkunde (01-03-2010)
    “…The aim of this study was to evaluate the clinical outcomes of the combination therapy with intravitreal recombinant tissue plasminogen activator (rTPA), gas…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Femtosecond laser capsulotomy versus manual technique: A clinico‐morphological study of the resected capsules by MEYER, P, PRUENTE, CH

    Published in Acta ophthalmologica (Oxford, England) (01-08-2013)
    “…Purpose To compare resected lens capsules created by femtosecond laser system with the conventional manual techniques. Methods A prospective, observational…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Early postoperative recovery of idiopathic macular hole in a young adult by Gassmann, K, Hasler, P W, Braun, B, Prünte, C

    “…Idiopathic macular holes usually develop in the elderly. We report the case of a spontaneous macular hole in a 23-year-old man. The patient noticed decreased…”
    Get more information
    Journal Article
  20. 20

    Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus by Braun, B, Schneider, U, Hasler, P, Prünte, C

    “…Photodynamic therapy (PDT) performed in this rare condition showed promising results according to 3 other case reports. A 47-year-old female patient with…”
    Get more information
    Journal Article